57
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28276 |
OV-potentiator-28
OV potentiator 28 |
||
OV-potentiator-28 is a potentiator of cancer virotherapy. OV-potentiator-28 significantly enhances virus replication-associated luciferase expression, specifically in tumors. | |||
T25173 |
Bradykinin potentiator-5
BPP-5a\,BPP 5a\,BPP5a\ |
||
Bradykinin potentiator-5 is a peptide inflammatory mediator, causes blood vessels to dilate (enlarge), and therefore causes blood pressure to fall. | |||
T76505 |
Bradykinin potentiator B
|
||
Bradykinin potentiator B 是 Agkistrodon halys blomhoffi 的毒液。Bradykinin potentiator B 是一种有效的 ACE 抑制剂。Bradykinin potentiator B 抑制缓激肽抑制肽酶的活性。 | |||
T76507 |
Bradykinin potentiator C
|
||
Bradykinin potentiator C是一种有效的血管紧张素转化酶(ACE)抑制剂,对兔肺ACE的IC50值为7.1 μM,被认为是功能肽原型。 | |||
T63003 |
NMDA receptor potentiator-1
|
||
NMDA receptor potentiator-1 (Compound 1368) 是一种亚基选择性的 NMDA receptor 增强剂。NMDA receptor potentiator-1 对 NR2C 和 NR2D 表达的 IC50 值分别为 4 μM 和 5 μM。 | |||
T23515 |
VU-29
VU 29 |
GluR | Neuroscience |
VU-29 是代谢型谷氨酸 5(mGlu5)受体的正变构调节剂,对 rmGluR5 的 EC50为 9 nM,Ki 为 244 nM。相对于其他亚型,它对 mGluR5 具有选择性,对 rmGluR1/rmGluR2和 hmGluR4的 EC50分别为557 nM/1.5 μM 和 154 nM。 | |||
T9499 |
Icenticaftor
QBW251 |
CFTR | Membrane transporter/Ion channel |
Icenticaftor (QBW251) 是一种具有口服活性CFTR 通道增强剂,可用于慢性阻塞性肺疾病 (COPD) 和囊性纤维化研究,对F508del 和G551D CFTR 的EC50分别为 79 和 497 nM。 | |||
T15820 |
Mibampator
LY451395 |
iGluR | Membrane transporter/Ion channel; Neuroscience |
Mibampator (LY451395) 是一种有效和选择性的 AMPA 受体增效剂。 | |||
T17238 |
VU0152100
VU152100 |
AChR | Neuroscience |
VU0152100 是一种选择性 M4 mAChR 变构增强剂,EC50为 380 ± 93 nM。 | |||
T7083 |
GLPG1837
ABBV-974 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
GLPG1837 (ABBV-974) 是一种有效的 CFTR 增强剂,对其 F508del 和 G551D 的 EC50 分别为 3 nM 和 339 nM。 | |||
TQ0289 |
LY450108
|
iGluR | Membrane transporter/Ion channel; Neuroscience |
LY450108 是有效的AMPA 受体增强剂,在抑郁和帕金森氏病中有研究的潜力。 | |||
T23513 |
VU10010
VU 10010 |
AChR | Neuroscience |
VU10010 (VU 10010) 是一种高度选择性的M4mAChR 变构增强剂,EC50为 400 nM。它与 M4mAChR 的变构位点结合,增强与 G 蛋白偶联,增加对乙酰胆碱的亲和力,还会增加卡巴胆碱引起的兴奋性传导抑制。 | |||
T14971 |
CIQ
|
NMDAR | Neuroscience |
CIQ 是亚基选择性NMDA 受体增强剂,可作用于NR2C 或NR2D 亚基。 | |||
T2588 |
Ivacaftor
Ivacaftor (VX-770),VX-770,依伐卡托 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Ivacaftor (VX-770) 是一种 CFTR 增强剂,靶向G551D-CFTR 和F508del-CFTR 的EC50分别为100 和 25 nM。 | |||
T29123 |
VU0152099
VU 0152099,VU-0152099 |
AChR | Neuroscience |
VU0152099 是选择性和可透过血脑屏障的 mAChR M4正变构调节剂,可增强 M4 对乙酰胆碱的反应,对大鼠 M4 受体的 EC50为 0.4 µM。 | |||
T61301 |
Chromenone 1
|
TGF-beta/Smad | Stem Cells |
Chromenone 1 是一种有效的成骨骨形态发生蛋白(BMP)增强剂,其通过诱导显著的非激酶依赖的负TGFβ反馈,独特地增强了核BMP-Smad信号输出。 | |||
T4573 |
Cyclothiazide
|
GluR | Neuroscience |
Cyclothiazide 是AMPA 受体的正变构调节剂,可快速抑制 AMPA 受体脱敏,并缓慢增强 AMPA 电流。它可以阻断天然和异源表达的AMPA 受体脱敏。 | |||
T8779 |
HBT1
|
GluR | Neuroscience |
HBT1 是一种 AMPA 受体增强剂,可诱导脑源性神经营养因子 (BDNF) 的产生,并且在原代神经元中几乎没有激动作用。 HBT1 以谷氨酸依赖的方式与 AMPA-R 的配体结合结构域结合。 | |||
T8890 |
653-47 hydrochloride
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
653-47 hydrochloride 是一种增强剂,能显著增强 666-15 的 cAMP 反应元件结合蛋白 (CREB) 抑制活性。它也是 CREB 抑制剂,IC50为 26.3 μM。 | |||
T16516 |
PG01
Phenylglycine-01 |
CFTR | Membrane transporter/Ion channel |
PG01是一种有效的CFTR Cl-通道增效剂,PG01对 ΔF508(Ka 为 0.3 μM)有效。PG01 对 E193K,G970R 和 G551D (CFTR 突变体)也 有效,Kd 值分别为 0.22 μM,0.45 μM 和 1.94 μM 。PG01在加入Forskolin 后可增加ΔF508-CFTR Cl-电流,纠正CFTR 突变体的门控缺陷。 | |||
T22720 |
3,3'-Difluorobenzaldazine
DFB |
Others | Others |
allosteric potentiator of mGlu5 | |||
T24916 |
UBP646
UBP-646,UBP 646 |
||
UBP646 is a GluN1/GluN2 receptors potentiator. | |||
T26263 |
TG3-95-1
TG3951,TG 3951,TG-3951 |
||
TG3-95-1 is an EP2 allosteric potentiator agent. | |||
T24010 |
DNAC-1
DNAC 1,DNAC1 |
||
DNAC-1 is against Gram-positive and Gram-negative pathogens potentiator of β-lactam activity. | |||
T23020 |
MRS 2219
|
Others | Others |
P2X1 receptor potentiator | |||
T14615 |
Biphenylindanone A
BINA |
GluR | Neuroscience |
Biphenylindanone A is a selective potentiator of human mGluR2 (hmGluR2),and for the treatment of neurological disorders. | |||
T13742L |
Ivacaftor hydrate
VX-770 hydrate |
Others | Others |
Ivacaftor hydrate is an orally bioavailable CFTR potentiator. It also is used for cystic fibrosis treatment. | |||
T27935 |
LY2607540
LY-2607540,THIIC,LY 2607540 |
||
LY2607540 is a metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties (EC(50) = 23 and 13 nM, respectively). | |||
T24268 |
KP-544
KP 544 |
||
KP-544 is an agent of neurotrophin potentiator. | |||
T27953 |
LY-395153
LY 395153,LY395153 |
||
LY-395153 is a novel potentiator of AMPA receptor. | |||
T23130 |
PD 81723
|
Others | Others |
Allosteric potentiator at the adenosine A1 receptor | |||
T70880 |
TAK-137
|
||
TAK-137 is a novel AMPA receptor potentiator with little agonistic effect, producing antidepressant-like effect without causing psychotomimetic effects. | |||
T0368L |
Cinepazide
Brendil,MD67350,Vasodistal,Cinepazide free base,MD-67350,MD 67350,NSC 291562 |
||
Cinepazide is a vasodilator used for the treatment of cardiovascular, cerebrovascular, and peripheral vascular diseases. Cinepazide acts as a potentiator of adenosine A2 receptors. | |||
T13742 |
Ivacaftor benzenesulfonate
VX-770 benzenesulfonate |
Others | Others |
Ivacaftor benzenesulfonate used for cystic fibrosis treatment. is an orally bioavailable CFTR potentiator. | |||
T24767 |
SBI-0069332
|
||
SBI-0069332 is a potentiator of metabotropic glutamate receptors. It was used against neurological and psychiatric disorders. | |||
T39596 |
Dirocaftor
PTI-808 |
||
Dirocaftor (PTI-808) is a CFTR potentiator that augments CFTR protein function via the activation of chloride channels. Dirocaftor holds potential utility for research pertaining to cystic fibrosis (CF). | |||
T13705 | GLPG2451 | Cysteine Protease | Proteases/Proteasome |
GLPG2451 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator. It effectively potentiates low temperature rescued F508del CFTR (EC50: 11.1 nM). | |||
TP1089 |
SPR741 TFA (1179330-52-9 free base)
NAB741 TFA,SPR741 TFA |
||
SPR741 TFA (NAB741 TFA) is a cationic peptide derived from polymyxin B and is a potentiator molecule. | |||
T22939 |
LY 2087101
|
Others | Others |
Allosteric potentiator of α7, α4β2 and α4β4 nAChRs | |||
T24551 |
NSC339614 potassium
NSC 339614 potassium,NSC-339614 potassium,NSC339614 potassium salt |
||
NSC339614 potassium is a selective GluN1/GluN2C and GluN1/GluN2D receptors potentiator. | |||
T27959 |
LY503430
LY-503430,LY 503430 |
||
LY503430 is a AMPA receptor potentiator with oral activity. LY503430 has both nootropic and neuroprotective effects, reducing brain damage caused by 6-hydroxydopamine or MPTP. | |||
T40386 |
CP-628006
|
||
CP-628006 is a small molecule CFTR potentiator that effectively restores ATP-dependent channel gating to G551D-CFTR, the mutant form found in cystic fibrosis. | |||
T24766 |
SBI-0061869
SBI0061869 |
||
SBI-0061869 is a potentiator of metabotropic glutamate receptors. It was used against neurological and psychiatric disorders. | |||
T25508 |
HUHS2002
HUHS 2002,HUHS-2002 |
||
HUHS2002 is a free fatty acid derivative that works as a potentiator of GluA1 AMPA receptor responses and α7 ACh receptor responses. | |||
T38936 |
KRAS G13D peptide, 25 mer
KRAS G13D peptide, 25 mer |
||
KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a KRAS vaccine. | |||
T71975 |
5-MPEP
|
||
5-MPEP is a neutral allosteric site ligand of the metabotropic glutamate receptor subtype 5 (mGlu5), blocking the effects of both the allosteric antagonist MPEP and potentiator CDPPB. | |||
T13691 |
Etifoxine
HOE 36-801 |
Others | Others |
Etifoxine preferentially acts on β2 or β3 subunit-containing GABAA receptors. GABAA receptor Etifoxine exhibits anxiolytic activity in rodents and humans with no sedative, myorelaxant or mnesic side effects. Etifoxine acts as a ligand of the translocator protein (TSPO); promotes axonal regeneration. Etifoxine(HOE 36-801) is potentiator of GABAA receptor function in cultured neurons. | |||
T37686 |
CFTR corrector 6
|
||
CFTR corrector 6 is a highly effective CFTR potentiator utilized in research on cystic fibrosis (CF) and related CFTR-associated disorders[1]. This potent compound exhibits potentiation activity on the Cystic Fibrosis Transmembrane conductance Regulator (CFTR), rendering it beneficial for investigations in CF and other associated conditions. | |||
T61655 |
AM-1488
|
||
AM1488 是一种有效的、具有口服活性的甘氨酸受体 (GlyR) 增效剂 (hGlyRα3EC50=0.45 μM)。 | |||
T8889 |
653-47
|
||
653-47 是一种增强剂,能显著增强 666-15 的 cAMP 反应元件结合蛋白(CREB)抑制活性。653-47 也是一种非常弱的CREB 抑制剂,IC50值为 26.3 μM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T23172 |
Polygodial
Tadeonal,水蓼二醛 |
Antifungal | Microbiology/Virology |
Polygodial (Tadeonal) 是一种抗真菌增效剂和抗生素。它是一种倍半萜,具有抗痛觉过敏的作用。 | |||
T0086 |
Galanthamine hydrobromide
Galantamine hydrobromide,Galanthamine HBr,氢溴酸加兰他敏 |
AChR; AChE | Neuroscience |
Galanthamine hydrobromide (Galantamine hydrobromide) 是一种长效的中枢活性 AChE 抑制剂,IC50为 410 nM。它是神经元烟碱型 ACh 受体的变构增强剂,IC50值为 0.35 µM,可用于阿尔茨海默症的研究。 | |||
T81676 |
NG-012
|
||
NG-012为一种神经生长因子(NGF)增强剂,来源于Penicillium verruculosum F-4542的培养液。该化合物能在大鼠嗜铬细胞瘤细胞系(PC12)中提升NGF引导的神经突生长效应。 |